Can PSA Levels Go Down? Causes and What a Decrease Means

PSA levels can absolutely go down, and they do so for a wide range of reasons. A dropping PSA number might reflect successful treatment for prostate cancer, resolution of an infection, a new medication, weight changes, or even just normal biological fluctuation from one blood draw to the next. The direction of the change matters less than the context behind it. A PSA decrease after radiation therapy for cancer means something very different from one caused by a statin you started taking for cholesterol, and both are different from a dip that is simply your body’s natural noise between tests.

Normal PSA Fluctuation Is Bigger Than Most People Realize

Your PSA level is not a fixed number. Even in a completely healthy prostate, PSA readings bounce around from test to test. In men with PSA levels below 2 ng/mL, the natural long-term variability for total PSA is less than about 14%, and a change greater than roughly 30% is needed before you can be confident it reflects something real rather than random fluctuation.¹ A broader survey of published data puts the average biological variation at around 20% for men over 50, meaning a single PSA result could be about a third higher or lower than your “true” average just by chance.²

This is why urologists usually do not panic over a single reading that is slightly different from the last one. If your PSA dropped from 3.2 to 2.7 between annual tests, that could easily be normal variation. A change of about 50% between two serial measurements is what researchers consider statistically meaningful for an individual patient.² Smaller swings, up or down, should generally be watched over time rather than acted on in isolation.

Medications That Bring PSA Down

Drugs Prescribed Specifically for the Prostate

The most dramatic medication-driven PSA drops come from 5-alpha reductase inhibitors, the drugs prescribed for an enlarged prostate (benign prostatic hyperplasia, or BPH). Finasteride and dutasteride work by blocking the enzyme that converts testosterone into dihydrotestosterone (DHT), a hormone that drives prostate growth. Finasteride reduces DHT levels in the prostate by roughly 80 to 90% within two weeks, and after about a year of use, prostate volume can shrink by around 20%.³ Less prostate tissue means less PSA in the blood. The general rule of thumb clinicians use is that these drugs cut PSA roughly in half after six months to a year, and many doctors will double a patient’s measured PSA value when interpreting results during treatment.

If you are taking finasteride or dutasteride, a declining PSA is expected and does not mean anything good or bad about cancer risk on its own. But if your PSA rises while you are on one of these drugs, that is something your doctor will pay close attention to, because the medication should be pushing it down.

Medications Not Prescribed for the Prostate

Several commonly used drugs that have nothing to do with the prostate also nudge PSA levels lower. An analysis of national survey data found that long-term use of NSAIDs (things like ibuprofen or naproxen), statins (cholesterol-lowering drugs), and thiazide diuretics (a type of blood pressure medication) were all associated with lower PSA. Five years of use was linked to PSA reductions of about 6% for NSAIDs, 13% for statins, and 26% for thiazide diuretics.⁴

Statins have received particular attention. Research tracking men before and after they started a statin found a median PSA decline of about 4% overall, and the drop was closely tied to how much their LDL cholesterol fell. Among men whose PSA was already in the range where a biopsy might be considered (2.5 ng/mL or higher), those with the largest LDL reductions saw PSA drop by more than 17%.⁵ The concern here is that the lower PSA might mask an underlying cancer that would otherwise have been caught, though the clinical significance of that effect is still debated.

If you have recently started any of these medications and your next PSA test comes back lower than expected, it is worth mentioning the new drug to whoever is reading your results.

Treating Infection and Inflammation

Prostatitis, whether from a bacterial infection or chronic inflammation, can spike PSA levels substantially. When that inflammation resolves, PSA drops back down. This is common enough that some urologists will prescribe a course of antibiotics before scheduling a biopsy for a man with a mildly elevated PSA and signs of possible infection.

In one study of men with elevated PSA who were given antibiotics, about 30% had a treatment response defined as a PSA decrease of more than 20% from baseline.⁶ Another study found that treated patients saw a significant PSA decline (from an average of about 7.0 ng/mL down to about 5.8 ng/mL), and the improvement was concentrated in men whose biopsies showed inflammation rather than cancer.⁷ In other words, when infection or inflammation was the cause of the elevated PSA, treating it brought levels back down. When cancer was the culprit, antibiotics did not help.

A PSA drop after antibiotics is generally reassuring, but it does not definitively rule out cancer. Some men have both inflammation and cancer at the same time. Your doctor may still recommend follow-up testing.

Body Weight and the Dilution Effect

Heavier men tend to have lower PSA readings, and the reason is surprisingly mechanical. As body mass increases, blood plasma volume increases too. Men with a BMI of 35 or higher have roughly 21 to 23% more plasma volume than men at a normal weight, and their PSA concentrations run about 11 to 21% lower, essentially because the same amount of PSA is diluted in a larger pool of blood.⁸

Lower androgen levels in obese men might also play a small role, since testosterone helps drive PSA production. But research suggests that decreased testosterone and DHT account for only about a fifth of the lower PSA seen in heavier men. The rest is likely attributable to the dilution effect of having more blood volume.⁹

This has a worrying implication for cancer detection. If you gain a significant amount of weight between PSA tests, your next reading may come in lower simply because of dilution, not because anything changed in your prostate. Conversely, significant weight loss could make PSA appear to rise even if your prostate is stable. If your weight has changed meaningfully between tests, it is worth flagging when discussing results.

Surgery for an Enlarged Prostate

Transurethral resection of the prostate (TURP), one of the standard surgical procedures for BPH, physically removes prostate tissue. Less tissue produces less PSA, so a substantial drop is expected. In one study, mean PSA fell by 71% after TURP, with the lowest point arriving about 60 days after surgery. Pre-operative PSA averaged about 6.2 ng/mL and fell to roughly 1.8 ng/mL.¹⁰ The degree of the PSA drop was proportional to how much tissue was removed.

After surgery for BPH, a new baseline PSA level is established once the post-surgical inflammation settles, usually a few months later. Any future PSA monitoring is then measured against that new, lower number. A significant rise from the new post-surgical baseline deserves the same attention as a rise in any other context.¹¹

PSA After Cancer Treatment

Radical Prostatectomy and Radiation

When the prostate is removed entirely (radical prostatectomy), PSA should fall to undetectable levels within a few weeks, because the organ that produces PSA is gone. If it does not drop to essentially zero, or if it later begins to rise from undetectable, that signals residual or recurrent cancer.

After radiation therapy, the picture is more complicated. PSA declines gradually over months or even years rather than disappearing overnight, because the prostate is still physically present but the cancer cells within it are dying off. Research has suggested that for most patients to be considered successfully treated, the PSA nadir (the lowest point it reaches) should be 0.5 ng/mL or below, which has been used as a reasonable indicator of long-term disease-free survival.¹² A nadir that never drops that low, or that takes a very long time to get there, can be a warning sign.

Androgen Deprivation Therapy

Androgen deprivation therapy (ADT), which suppresses testosterone to slow cancer growth, also lowers PSA. Since testosterone stimulates PSA production, cutting off that signal causes levels to fall, often dramatically. How low PSA goes and how quickly it gets there both carry prognostic information. Research has found that patients who reach a PSA nadir of 0.2 ng/mL or higher, or who reach their lowest point in less than six months, face a significantly higher risk of progressing to castration-resistant disease compared to those who achieve a deeper, slower nadir.¹³ In practical terms, a quick but shallow PSA drop on ADT is more concerning than a slow, deep decline.

The PSA Bounce After Radiation

One pattern that causes enormous anxiety is the PSA bounce. After radiation, some men experience a temporary rise in PSA (defined in studies as an increase of 0.2 ng/mL or more above the nadir) followed by a decline back down to nadir or below.¹⁴ The bounce is thought to result from delayed inflammation or cell death in irradiated tissue and is not necessarily a sign of recurrence. It commonly occurs one to three years after treatment and can happen more than once.

Distinguishing a benign bounce from true biochemical recurrence is one of the trickier calls in prostate cancer follow-up. The key difference is that a bounce is self-resolving: PSA goes up temporarily and then comes back down on its own. If PSA keeps climbing without reversing, the pattern points toward recurrence rather than bounce.¹⁵ Patience and serial testing are usually the approach, since intervening too early based on what turns out to be a bounce could lead to unnecessary treatment.

Diet, Exercise, and Lifestyle

There is modest evidence that lifestyle changes can influence PSA levels, though the effects are far smaller than those from medications or surgery. A systematic review of plant-based dietary interventions in men with prostate cancer found that patients who adopted intensive plant-based diets experienced a significant improvement in PSA compared to controls at one year, with the degree of improvement correlated with the extent of dietary change. At two years, though, the PSA differences between groups were no longer statistically significant.¹⁶ What was notable was that far fewer men in the dietary intervention group went on to need conventional treatment, suggesting possible clinical benefit beyond PSA numbers alone.

Exercise has also been studied, though largely in the context of active surveillance. Research tracking men with localized prostate cancer found that higher weighted exercise scores were associated with modestly lower PSA levels, about 2% lower for each unit increase in their exercise score. Current smokers, by contrast, had PSA levels roughly 25% higher than never smokers.¹⁷ These are associations rather than proven causal effects, but they suggest that general health habits contribute to the PSA picture.

One thing that does not appear to lower PSA is cycling. Despite long-standing concern that bicycle seats might affect the prostate, a study of professional cyclists found no effect of rigorous bicycle riding on total or free PSA levels.¹⁸

Supplements That Claim to Lower PSA

Saw palmetto is probably the most widely marketed herbal supplement for prostate health, and many men take it with the expectation that it will improve their PSA numbers. A well-designed randomized trial that tested escalating doses of saw palmetto extract over 72 weeks found that it was no more effective than placebo at lowering PSA. The mean change from baseline was nearly identical between the saw palmetto and placebo groups throughout the study.¹⁹ If you notice your PSA dropping while taking saw palmetto, the supplement is very likely not the reason.

This is worth knowing because some men may attribute a PSA decline to a supplement they are taking and feel falsely reassured, potentially delaying evaluation for other causes. If your PSA drops, the explanation almost certainly lies elsewhere.

When the Lab Itself Creates the Change

Not all apparent PSA changes reflect something happening inside your body. Different PSA assays used by different laboratories can produce meaningfully different numbers from the exact same blood sample. Research has shown that PSA values can vary by as much as a factor of two depending on which assay is used.²⁰ If you had your first test done at one clinic and your follow-up at a different lab, an apparent drop or rise in PSA could be an artifact of the testing method rather than a biological change.

The practical takeaway is straightforward: whenever possible, get your PSA tested at the same laboratory each time. If you switch labs or your doctor’s office changes its testing vendor, make sure whoever is reading the results knows. A two-fold difference in readings from two different assays could easily turn a stable PSA into what looks like a dramatic improvement or, worse, a concerning spike.

When a Falling PSA Is Not Reassuring

Most of the time, a declining PSA is either neutral (normal fluctuation, lab artifact) or genuinely good news (successful treatment, resolved infection). But there are a few situations where a dropping PSA should prompt closer evaluation rather than relief.

If you are on ADT or another cancer treatment and your PSA drops very quickly but does not reach a very low nadir, that pattern has been linked to faster progression to treatment-resistant disease, as described above. A rapid partial response can be a worse sign than a slow but complete one.

In rare aggressive subtypes of prostate cancer, particularly those that undergo neuroendocrine differentiation, PSA can actually decline as the cancer becomes less dependent on androgen signaling. These tumors may stop producing PSA even as they grow, meaning the falling number gives a falsely reassuring picture. This is uncommon, but it underscores why PSA is only one piece of the monitoring puzzle and is always interpreted alongside imaging, symptoms, and clinical exam.

If your PSA drops but you develop new symptoms like bone pain, urinary changes, or unexplained weight loss, the PSA trend alone should not be treated as evidence that everything is fine. PSA is a useful tool, but it is not the complete story of what your prostate is doing.